CIK 0001544227
- Non-accelerated filer
- Smaller reporting company
Tempest Therapeutics, Inc.
Sign in to watch- Ticker
- TPST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 451472564
- Phone
- +1 415-798-8589
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 400, BRISBANE, CA, 94005
- Former names
- Millendo Therapeutics, Inc., OvaScience, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-02 | Couturier Christophe Chief Financial Officer | Grant or award · Stock Option (right to buy) | +45,750 | 45,750 | ||
| 2017-01-05 | Couturier Christophe Chief Financial Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2016-12-23 | Couturier Christophe Chief Financial Officer | Grant or award | +300 | $1.44 | $431 | 50,900 |
| 2016-09-08 | Couturier Christophe Chief Financial Officer | Grant or award | +50,000 | 50,600 | ||
| 2016-09-08 | Couturier Christophe Chief Financial Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 |
Page 1 of 1 · 5 trades